Literature DB >> 23893846

Can the mild clinical course of crimean-congo hemorrhagic fever in children be explained by cytokine responses?

Yasemin Ozsurekci1, Mehmet Arasli, Eda Karadag Oncel, Dilek Yagci Caglayik, Ali Kaya, Fusun Dilara Icagasioglu, Aynur Engin, Gulay Korukluoglu, Nazif Elaldi, Mehmet Ceyhan.   

Abstract

Cytokines are possibly one of the factors responsible for death due to Crimean-Congo hemorrhagic fever (CCHF). This study aimed to determine the differences between the cytokine levels in children and adult patients with CCHF; the influence of cytokines; and the severity of the course of the disease, which seems to be milder in children. Thirty-four children and 36 adult patients diagnosed with CCHF between 2010 and 2011 were included in this study. Diagnosis was performed by serology or by the polymerase chain reaction for CCHF virus. Levels of IFN-γ, TNF-α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 p70, IL-13, IL-17A, and IL-22 were measured in all serum samples. Although the disease had a fatal course in three adult patients, there were no deaths in children. Statistically significant differences were not observed between the cytokine concentrations in the adults and children. No differences were detected between the serum cytokine levels in the children with moderate and those with a severe clinical course of the disease. In the adult patients with fatal outcome, significantly higher serum levels of IL-2, IL-5, IL-9, IL-12 p70, and IL-13 were detected as compared to the cytokine levels in patients who survived the infection. No differences were detected between the serum levels of IFN-γ, IL-1β, IL-17A, IL-22, IL-10, IL-6, IL-4, and TNF-α in the patients who died and those who survived. Thus, the milder clinical course in children with CCHF cannot be explained by the cytokine network alone. The incomplete maturation of the immune system and timing and scale of immune responses could change the outcome dramatically.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Crimean-Congo hemorrhagic fever; adults; children; cytokine; severity of disease

Mesh:

Substances:

Year:  2013        PMID: 23893846     DOI: 10.1002/jmv.23697

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Evaluation of cytokines as Th1/Th2 markers in pathogenesis of children with Crimean-Congo hemorrhagic fever.

Authors:  Enver Sancakdar; Ahmet Sami Güven; Elif Bilge Uysal; Ali Kaya; Köksal Deveci; Hekim Karapınar; Ismail Akkar
Journal:  Int J Clin Exp Med       Date:  2014-03-15

2.  A Pediatric Case of Severe Fever with Thrombocytopenia Syndrome in Korea.

Authors:  Tae Yang Song; Eun Mi Yang; Chan Jong Kim
Journal:  J Korean Med Sci       Date:  2017-04       Impact factor: 2.153

3.  The effect of inflammatory cytokines and the level of vitamin D on prognosis in Crimean-Congo hemorrhagic fever.

Authors:  Emine Parlak; Ayşe Ertürk; Yasemin Çağ; Engin Sebin; Musa Gümüşdere
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  Characterization of Biomarker Levels in Crimean-Congo Hemorrhagic Fever and Hantavirus Fever with Renal Syndrome.

Authors:  Miša Korva; Katarina Resman Rus; Miša Pavletič; Ana Saksida; Nataša Knap; Mateja Jelovšek; Katja Strašek Smrdel; Xhevat Jakupi; Isme Humolli; Jusuf Dedushaj; Miroslav Petrovec; Tatjana Avšič-Županc
Journal:  Viruses       Date:  2019-07-26       Impact factor: 5.048

5.  Outcome predictors of influenza for hospitalization and mortality in children.

Authors:  Yasemin Ozsurekci; Kubra Aykac; Fatma Bal; Cihangul Bayhan; Sevgen T Basaranoglu; Alpaslan Alp; Ali Bulent Cengiz; Ates Kara; Mehmet Ceyhan
Journal:  J Med Virol       Date:  2021-02-09       Impact factor: 20.693

6.  Severe fever with thrombocytopenia syndrome in children: a case report.

Authors:  Li-Yuan Wang; Ning Cui; Qing-Bin Lu; Ying Wo; Hong-Yu Wang; Wei Liu; Wu-Chun Cao
Journal:  BMC Infect Dis       Date:  2014-07-03       Impact factor: 3.090

7.  Pediatric huaiyangshan virus infection: A case report with literature review.

Authors:  Chun-Hui Zhu; Dong Xu; Wei Liu; Di Guo; Qin Ning; Guang Chen
Journal:  IDCases       Date:  2017-05-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.